|Articles|July 22, 1998
Advanced Magnetics inks university deal
Pharmaceutical developer Advanced Magnetics of Cambridge, MA, has signed a research agreement to develop new nucleoside therapeutic drugs with the University of Minnesota in Minneapolis. Under the deal, Advanced Magnetics over the next three years will
Advertisement
Pharmaceutical developer Advanced Magnetics of Cambridge, MA, has signed a research agreement to develop new nucleoside therapeutic drugs with the University of Minnesota in Minneapolis. Under the deal, Advanced Magnetics over the next three years will sponsor research led by Dr. Carston Wagner to develop drug candidates with anti-viral or anti-tumor characteristics. The deal is part of the companys plan to diversify from its core MRI contrast agent market (SCAN 3/18/98).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
New Ultrasound Contrast Delivery System Garners FDA 510(k) Clearance
2
Molecular Imaging in Focus: PSMA PET Pioneer Martin Pomper, MD, PhD Traces PSMA’s Origins and the Path Ahead for Theranostics in Prostate Cancer
3
Breast MRI Study Reveals 29 Percent Reduction in Scan Time with Deep Learning Reconstruction and Multi-Shot DWI
4
The Weight of Numbers in Radiology
5








